Zivo Bioscience
(ZIVO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3 | 139 | 274 | 1,485 | 21 |
| Receivables | N/A | 4 | 4 | 3 | N/A |
| TOTAL | $495 | $711 | $425 | $1,948 | $530 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 81 | 106 | 130 | 154 | 180 |
| TOTAL | $81 | $106 | $130 | $154 | $180 |
| Total Assets | $576 | $816 | $556 | $2,102 | $710 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,700 | 1,617 | 1,406 | 2,014 | 2,625 |
| Accrued Expenses | 1,105 | 101 | 101 | 149 | 124 |
| Other current liabilities | 15 | N/A | N/A | N/A | N/A |
| TOTAL | $2,871 | $3,085 | $2,762 | $3,174 | $3,804 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 77 | 267 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 22 | 51 |
| TOTAL | $N/A | $N/A | $N/A | $22 | $51 |
| Total Liabilities | $2,871 | $3,085 | $2,762 | $3,196 | $3,855 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,366 | 2,832 | 2,778 | 1,820 | 1,742 |
| Common Shares | 3 | 3 | 2 | 2 | 9 |
| Retained earnings | -133,097 | -124,860 | -123,582 | -121,673 | -119,848 |
| TOTAL | $-2,296 | $-2,269 | $-2,206 | $-1,094 | $-3,145 |
| Total Liabilities And Equity | $576 | $816 | $556 | $2,102 | $710 |